| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,448 |
9,016 |
$2.22M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,501 |
8,095 |
$1.27M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,340 |
4,845 |
$405K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
37,204 |
35,638 |
$394K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
647 |
611 |
$204K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,548 |
1,520 |
$138K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
790 |
758 |
$103K |
| 59025 |
Fetal non-stress test |
651 |
357 |
$79K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
725 |
676 |
$72K |
| 62323 |
|
133 |
128 |
$52K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
813 |
782 |
$46K |
| 36415 |
Collection of venous blood by venipuncture |
16,309 |
14,128 |
$36K |
| 20552 |
|
134 |
130 |
$24K |
| 71046 |
Radiologic examination, chest; 2 views |
444 |
418 |
$22K |
| 80061 |
Lipid panel |
1,703 |
1,641 |
$19K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,452 |
1,394 |
$17K |
| 20610 |
|
106 |
93 |
$17K |
| 80053 |
Comprehensive metabolic panel |
7,965 |
7,573 |
$16K |
| 97597 |
|
138 |
67 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,016 |
1,963 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,678 |
11,059 |
$12K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
119 |
112 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
215 |
207 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
478 |
467 |
$7K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
16 |
16 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
800 |
741 |
$5K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,488 |
1,401 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
898 |
854 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
45 |
43 |
$2K |
| 86900 |
|
28 |
27 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
123 |
121 |
$2K |
| 80076 |
|
352 |
328 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
111 |
100 |
$2K |
| 85027 |
|
746 |
710 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
31 |
31 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
180 |
170 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$1K |
| 86762 |
|
68 |
66 |
$814.74 |
| 87340 |
|
80 |
78 |
$569.37 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
163 |
158 |
$558.75 |
| 86593 |
|
269 |
258 |
$534.24 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
54 |
54 |
$443.00 |
| 86803 |
|
29 |
28 |
$292.57 |
| 84702 |
|
17 |
15 |
$264.90 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
128 |
124 |
$179.96 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
13 |
$117.15 |
| 83690 |
|
710 |
673 |
$112.86 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
14 |
13 |
$100.75 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
15 |
12 |
$73.89 |
| 81003 |
|
825 |
793 |
$63.50 |
| 83735 |
|
261 |
250 |
$38.22 |
| 81025 |
|
455 |
440 |
$32.72 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,087 |
500 |
$31.44 |
| 84484 |
|
173 |
129 |
$27.57 |
| 81001 |
|
112 |
106 |
$7.13 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
43 |
42 |
$6.90 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
26 |
24 |
$0.00 |
| 76942 |
|
27 |
24 |
$0.00 |
| 87081 |
|
206 |
197 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
71 |
65 |
$0.00 |
| 87430 |
|
272 |
260 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
35 |
32 |
$0.00 |
| 86901 |
|
28 |
27 |
$0.00 |
| 83605 |
|
13 |
12 |
$0.00 |
| 87807 |
|
17 |
16 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
13 |
12 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12 |
12 |
$0.00 |
| 86850 |
|
28 |
27 |
$0.00 |
| 86140 |
|
12 |
12 |
$0.00 |